https://www.clearnotehealth.com/publication/5-hydroxymethylcytosine-analysis-reveals-stable-epigenomic-changes-in-tumor-tissue-that-enable-cancer-detection-in-cell-free-dna-2/ 2026-02-02T04:16:37+00:00 https://www.clearnotehealth.com/publication/a-tumor-naive-method-for-estimating-tumor-fraction-using-5-hydroxymethylation-cytosine-in-cell-free-dna/ 2026-02-02T15:56:14+00:00 https://www.clearnotehealth.com/publication/analytical-validation-of-an-early-detection-pancreatic-cancer-test-using-5-hydroxymethylation-signatures/ 2026-02-02T15:57:46+00:00 https://www.clearnotehealth.com/publication/safe-d-trial-design-targeted-pancreatic-cancer-screening-to-evaluate-stage-and-resectability-rate-shift-in-patients-with-new-onset-diabetes/ 2026-02-02T16:01:47+00:00 https://www.clearnotehealth.com/publication/implementation-of-the-avantect-pancreatic-cancer-test-in-newly-diagnosed-type-2-diabetes-patients-in-a-clinical-setting/ 2026-02-02T16:02:49+00:00 https://www.clearnotehealth.com/publication/early-detection-of-pancreatic-cancer-using-5-hydroxymethylation-profiles-in-plasma-derived-cell-free-dna/ 2026-02-02T16:05:31+00:00 https://www.clearnotehealth.com/publication/plasma-cell-free-dna-hydroxymethylation-profiling-reveals-anti-pd-1-treatment-response-and-resistance-biology-in-non-small-cell-lung-cancer/ 2026-02-02T16:06:33+00:00 https://www.clearnotehealth.com/publication/epigenomic-blood-based-early-detection-of-pancreatic-cancer-employing-cell-free-dna/ 2026-02-02T16:08:09+00:00 https://www.clearnotehealth.com/publication/the-5-hydroxymethylcytosine-landscape-of-prostate-cancer/ 2026-02-02T16:09:05+00:00 https://www.clearnotehealth.com/publication/the-cell-type-specific-5hmc-landscape-and-dynamics-of-healthy-human-hematopoiesis-and-tet2-mutant-preleukemia/ 2026-02-02T16:12:51+00:00 https://www.clearnotehealth.com/publication/a-human-tissue-map-of-5-hydroxymethylcytosines-exhibits-tissue-specificity-through-gene-and-enhancer-modulation/ 2026-02-02T16:13:35+00:00 https://www.clearnotehealth.com/publication/detection-of-early-stage-pancreatic-cancer-using-5-hydroxymethylcytosine-signatures-in-circulating-cell-free-dna/ 2026-02-02T16:14:12+00:00 https://www.clearnotehealth.com/publication/pilot-study-demonstrating-changes-in-dna-hydroxymethylation-enable-detection-of-multiple-cancers-in-plasma-cell-free-dna/ 2026-02-02T16:15:01+00:00 https://www.clearnotehealth.com/publication/5-hydroxymethylcytosine-signatures-in-cell-free-dna-provide-information-about-tumor-types-and-stages/ 2026-02-02T16:15:45+00:00 https://www.clearnotehealth.com/publication/automation-of-an-early-detection-pancreatic-cancer-test-using-5-hydroxymethylation-profiles/ 2026-02-02T16:20:01+00:00 https://www.clearnotehealth.com/publication/cell-free-dna-5-hydroxymethylcytosine-profiling-for-the-assessment-of-colorectal-cancer-biology-and-treatment-response-in-blood/ 2026-02-02T16:20:30+00:00 https://www.clearnotehealth.com/publication/5hmc-seq-of-mcrpc-cfdna-identifies-loss-of-ar-signaling-in-nepc-and-dnpc/ 2026-02-02T16:20:47+00:00 https://www.clearnotehealth.com/publication/cell-free-dna-epigenomic-based-test-is-predicted-to-be-cost-effective-to-manage-new-onset-type-2-diabetes-patients-for-risk-of-pancreatic-cancer/ 2026-02-02T16:21:12+00:00 https://www.clearnotehealth.com/publication/detection-of-high-risk-pancreatic-cysts-using-avantect-blood-based-test/ 2026-02-02T16:21:31+00:00 https://www.clearnotehealth.com/publication/evaluation-of-the-avantect-pancreatic-cancer-test-for-identifying-high-risk-pancreatic-cysts/ 2026-02-02T17:26:50+00:00